Insomnia is a sleep disorder described as having a failure to sleep, stay asleep, and fall asleep again when waking up at improper time. This review is about the basic knowledge of Insomnia and the introduction of the pharmacology of two corresponding drugs-Zolpidem and Ramelteon. Zolpidem, with the brand name “Ambien,” is a non-benzodiazepine and works like Gamma-Aminobutyric Acid to inhibit neurotransmission activities throughout the nervous system, thereby bringing sedative effects to the brain. Ramelteon, also called “Rozerem,” functions as melatonin and attaches to the melatonin receptors on the Suprachiasmatic nucleus to block the neuronal firing and induce sleepiness. They are both very crucial pats of the sleep market. The research of Insomnia and two drugs-Zolpidem and Ramelteon-strengthens readers’ knowledge about typical sleep disorder and how drugs’ treatments work, as well as digging into the drug market and potential development.
Skip Nav Destination
Article navigation
19 December 2022
PROCEEDINGS OF THE 2021 INTERNATIONAL CONFERENCE ON BIOLOGICAL ENGINEERING AND MEDICAL SCIENCE
9–15 December 2021
Stanford, California, USA
Research Article|
December 19 2022
Two important drugs to treat insomnia: Zolpidem & ramelteon
Haoyue Li
Haoyue Li
a)
1
Department of Agricultural and Biological Engineering, Purdue University
, West Lafayette, 47906, Indiana, U.S.
a)Corresponding author: li3345@purdue.edu
Search for other works by this author on:
a)Corresponding author: li3345@purdue.edu
AIP Conf. Proc. 2589, 020035 (2022)
Citation
Haoyue Li; Two important drugs to treat insomnia: Zolpidem & ramelteon. AIP Conf. Proc. 19 December 2022; 2589 (1): 020035. https://doi.org/10.1063/5.0120644
Download citation file:
Sign in
Don't already have an account? Register
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
Sign in via your Institution
Sign in via your InstitutionPay-Per-View Access
$40.00
35
Views